Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report) was down 1.6% during trading on Wednesday . The company traded as low as $1.21 and last traded at $1.25. Approximately 263,962 shares traded hands during trading, an increase of 293% from the average daily volume of 67,097 shares. The stock had previously closed at $1.27.
Cardiol Therapeutics Price Performance
The business’s 50-day moving average price is $1.51 and its two-hundred day moving average price is $1.84.
About Cardiol Therapeutics
Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.
See Also
- Five stocks we like better than Cardiol Therapeutics
- What Investors Need to Know to Beat the Market
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- What is a support level?
- How Do Stock Buybacks Affect Shareholders?
- The 3 Best Fintech Stocks to Buy Now
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
